1-4 of 4
integrin alpha4beta1
Close
Sort by
Journal Articles

VLA4 Blockade In Acute Myeloid Leukemia

Yao-Te Hsieh, Enzi Jiang, MD, PhD, Jennifer Pham, Hye-Na Kim, Hisham Abdel-Azim, MD, Sajad Khazal, MD, Gesine Bug, MD, PhD, Gabriele Spohn, Ph.D., Halvard Bonig, MD, MA, Yong-Mi Kim, MD, MPH, PhD
Journal: Blood
Blood (2013) 122 (21): 3944.
https://doi.org/10.1182/blood.V122.21.3944.3944
Published: 2013
Journal Articles

The Small Molecule Inhibitor of VLA4 TBC3486 Sensitizes Resistant ALL to Chemotherapy

Yao-Te Hsieh, Eun Ji Gang, MD, PhD, Halvard Bonig, MD, MA, Ronald J Biediger, PhD, Peter Vanderslice, PhD, Yong-Mi Kim, MD, MPH, PhD
Journal: Blood
Blood (2012) 120 (21): 1500.
https://doi.org/10.1182/blood.V120.21.1500.1500
Published: 2012
Journal Articles

Potentiated Activation of VLA-4 and VLA-5 Accelerates Proplatelet-Like Formation In Megakaryocytes.

Takuya Matsunaga, MD, PhD, Fumio Fukai, PhD, Takuro Kameda, MD, Kotaro Shide, MD, PhD, Haruko Shimoda, MD, PhD, Eri Torii, Yasuhiro Taniguchi, Tomonori Hidaka, Keiko Katayose, Yoko Kubuki, Kazuya Shimoda, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2585.
https://doi.org/10.1182/blood.V116.21.2585.2585
Published: 2010
Journal Articles

Targeting of alpha4beta1 Integrin and CD4/CD8 on Human T Cells, in Addition to CD3 and CD28, Induces Maximal Activation, as Assessed by Single-Cell Analysis of MAP Kinase Pathway Activation and Cytokine Production.

Tae Kon Kim, M.D., Matthew J. Billard, Ph.D., Eric D. Wieder, Ph.D., Bradley W. McIntyre, Ph.D., Krishna V. Komanduri, M.D.
Journal: Blood
Blood (2008) 112 (11): 1538.
https://doi.org/10.1182/blood.V112.11.1538.1538
Published: 2008